Table 4.
ERCC2/XPD genotype |
p21 Biomarker |
Crude OR |
Adjusted ORa |
|||
---|---|---|---|---|---|---|
− | + | OR | 95% CI | OR | 95% CI | |
312 Asp-Asp | 172 | 51 | 1.0 | 1.0 | ||
Asp-Asn | 169 | 91 | 1.8 | 1.2–2.7 | 1.8 | 1.2–2.7 |
Asn-Asn | 34 | 29 | 2.9 | 1.6–5.1 | 3.0 | 1.6–5.4 |
751 Lys-Lys | 169 | 53 | 1.0 | 1.0 | ||
Lys-Gln | 168 | 88 | 1.7 | 1.1–2.5 | 1.6 | 1.1–2.5 |
Gln-Gln | 38 | 30 | 2.5 | 1.4–4.4 | 2.6 | 1.5–4.6 |
Adjusted for age, smoking, drinking and cumulative VC exposure; p for trend <0.0006.